Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
about
Disorders of carnitine transport and the carnitine cycleMitochondrial Trifunctional Protein Defects: Clinical Implications and Therapeutic ApproachesInborn errors of energy metabolism associated with myopathies.State of the art in muscle lipid diseases.Genotype-phenotype correlation in primary carnitine deficiencyDrug development for rare mitochondrial disordersResidual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency.Primary carnitine deficiency: novel mutations and insights into the cardiac phenotype.Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency.Rare diseases in clinical endocrinology: a taxonomic classification system.Enzymes involved in L-carnitine biosynthesis are expressed by small intestinal enterocytes in mice: implications for gut health.Carnitine transport and fatty acid oxidation.Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency.Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands.Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence.Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening.Treatment Opportunities in Patients With Metabolic Myopathies.Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events.Functional and molecular studies in primary carnitine deficiency.Attention deficit/hyperactivity disorder as an associated feature in OCTN2 deficiency with novel deletion (p.T440-Y449).Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum.Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury.
P2860
Q24658342-0AB2F59E-FC28-4EB9-A72A-0BCC9EBC65CBQ28972544-81BA60B5-88FB-403C-836F-9D35D0B4CBC4Q33879587-03BF5F55-5A23-4F59-9B96-D4A06B22007FQ34580810-52D82C3B-E0EF-4CF9-A32A-22EEEF17497EQ35618853-A37C131B-7044-4BD3-A389-FFC01628C989Q36762826-863CABD7-5A6E-4789-84BA-D7830B12DD42Q37434019-D42E5605-79B6-483C-8DCF-E8976438649BQ38078974-BBBE54BF-8594-42D1-83AC-EF748C59EB6AQ38190550-94CB28A4-1453-4780-8C28-56C6360B0EC2Q39102141-E57F85B9-09D8-4EE4-B647-454A9A709966Q40393464-4471F975-F358-49AE-8DF2-18ADB3F09E9EQ41633875-B5CFECEB-2B20-4CD0-A751-9A2565E08B16Q41779087-580F3C26-A9DF-4261-9586-542FA13CECACQ43776338-C114CA3E-978A-426D-B699-7F279D347E1EQ44882518-2A454053-5D7B-47DB-BCF1-9A58463CCE79Q44929080-915C0748-42FD-49A6-8F26-12D434454AA4Q45872248-6F54057C-08D3-4861-96F0-39DB824F52ABQ46912583-477F6833-6A9A-41E3-9B63-B1A1F32046E1Q47713614-07083DAF-9E7E-47C4-9A69-074017DBC43CQ52595078-6DD2AADE-9DFF-46C6-A5D6-2CD1BBCAA802Q53562541-F7F2DAE5-315B-4A97-A5A0-7ABA55AC7443Q54979643-5982EA17-6582-45D6-81BB-32EC03993B6E
P2860
Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Novel OCTN2 mutations: no geno ...... erapy prevents cardiomyopathy.
@en
Novel OCTN2 mutations: no geno ...... erapy prevents cardiomyopathy.
@nl
type
label
Novel OCTN2 mutations: no geno ...... erapy prevents cardiomyopathy.
@en
Novel OCTN2 mutations: no geno ...... erapy prevents cardiomyopathy.
@nl
prefLabel
Novel OCTN2 mutations: no geno ...... erapy prevents cardiomyopathy.
@en
Novel OCTN2 mutations: no geno ...... erapy prevents cardiomyopathy.
@nl
P2093
P2860
P356
P1476
Novel OCTN2 mutations: no geno ...... herapy prevents cardiomyopathy
@en
P2093
Anne-Marie Lamhonwah
Christine Vianey-Saban
Guy T N Besley
Ingrid Tein
Ksenija Fumic
Linda J De Meirleir
Ljerka Cvitanovic-Sojat
Miljenka Maradin
Nathalie Guffon
P2860
P304
P356
10.1002/AJMG.10585
P577
2002-08-01T00:00:00Z